The AVTOZMA® (tocilizumab-anoh) intravenous (IV) formulation was approved in January 2025 by the FDA to treat the same conditions as the reference product ACTEMRA® (tocilizumab) AVTOZMA is Celltrion's fifth immunology biologic and seventh biosimilar approved by the FDA This launch strengthens Celltrion's immunology portfolio beyond tumor-necrosis factor (TNF)-alpha and interleukin (IL)-12 and 23 inhibitors, to include an IL-6 inhibitor, broadening coverage across multiple inflammatory pathways and addressing a wider spectrum of diseases and patient populations I
- Record-high competition ratio of 56:1… Winning dish "Kimpacho" selected after final round among eight contestants - Kimchi recipes from professional chefs to home cooks draw attention SEOUL, South Korea, Oct. 2, 2025 -- Daesang's kimchi brand 'Jongga', together with the prestigious U.S. culinary school 'Institute of Culinary Education' and SF Globalize, successfully concluded the '2025 Jongga Kimchi Cook Off' in New York. The Jongga Kimchi Cook Off is a global event held across the U.S., U.K., and France to showcase the appeal and excellence of
[ 메디채널 김갑성 기자 ] Nanyang Biologics Pte. Ltd., together with its subsidiaries (collectively, the "Company", "we" or "NYB"), offers a comprehensive drug discovery platform that integrates the wisdom of traditional medicine with state-of-the-art technologies. Patented Flagship NB-A002 is a First-in-class DNA Damage Response ("DDR") therapeutic product candidate, targeting the previously undruggable target ILF2, inducing synthetic lethality in DDR and Homologous Recombination Deficiency Cancers. Patented Drug-Target Interaction Graph Neural Network (&qu
[ 메디채널 황정호 기자 ] School Cup Launched to Encourage Youngsters Continuing the Conservation SpiritThree Popular Routes across the Ecological Corridor of Hong Kong TrailSix Corporate Cups for Companies to Achieve ESG GoalsPromote Leave No Trace Together HONG KONG, Oct. 2, 2025 -- Organised by Green Power, the 33rd Green Power Hike - the great annual charity hiking event - will commence on 31 January (Saturday) 2026. Individuals and groups are welcome to participate in the 50km, 25km and 10km races. In addition to six Corporate Cups, a new category- School Cup - is created. We invite all s
[ 메디채널 김갑성 기자 ] 광저우, 중국 2025년 10월 2일 -- 리드 시노팜 엑시비션즈(Reed Sinopharm Exhibitions)가 주최하는 제92회 중국 국제 의료기기 박람회(CMEF 2025) 추계 전시회가 9월 26일부터 29일까지 광저우 캔톤 페어 콤플렉스(Canton Fair Complex)에서 진행됐다. 약 16만 제곱미터 면적에서 진행된 이 행사에는 20개 국가 및 지역 3천여개 업체가 신제품 1만여 점을 전시했으며, 160여개 국가에서 방문객 12만 명의 눈길을 사로잡았다. 의료 혁신과 고품질 개발을 선도하는 허브라는 CMEF의 지위가 다시 한번 확인되는 순간이었다. CMEF는 지난 40년 동안 제품 출시, 기술 교류, 조달, 학술 협력, 브랜드 구축을 망라하는 최고의 플랫폼으로 등극했다. 올해는 의료 영상, 체외 진단, 수술 로봇, 스마트 헬스케어 등 28개 테마 구역으로 구성되어 연구 개발부터 실제 적용까지 공급망 전체가 주목을 받았다. 전시회 하이라이트 의료 영상 구역: 국산 디지털 심장 단일광자 단층촬영(SPECT)과 대형 평판형 이동식 C-arm 등 '이미징 펄스-
[ 메디채널 김장윤(JASON KIM) 기자 ] 베이징 2025년 10월 2일 -- 중국 글로벌 텔레비전 네트워크(CGTN)의 보도자료: China International Online Literature Week Opens in Hangzhou, Highlighting an AI-Driven Future 지난주에 20개국의 외교관, 작가, 학자, 업계 전문가가 항저우에서 열린 2025년 중국 국제 온라인 문학 주간(2025 China International Online Literature Week)에 참석하여 인공지능이 세계 문학에 미치는 영향을 논의했으며. 이를 계기로 급성장 중인 중국의 온라인 문학 산업이 새삼 주목 받기도 했다. '새로운 동력, 새로운 국면, 새로운 차원: AI로 보강되는 온라인 문학의 범세계적 전망(New Momentum, New Landscape, New Dimension: Global Vision of AI-Empowered Online Literature)'이라는 주제로 일주일간 진행된 이번 행사에서는 기술이 급격히 발전하는 상황에서 이뤄지는 온라인 문학의 혁신적
[ 메디채널 김갑성 기자 ] Details of the Phase 3 MASCOT trial investigating amlenetug for the treatment of patients with Multiple System Atrophy (MSA) will be presented at the International Congress of Parkinson's Disease and Movement Disorders® 20251-3 MSA is a rare, rapidly progressing, neurodegenerative disease with no approved treatments available4,5 The innovative design of the pivotal MASCOT trial aims to accelerate drug development for patients living with MSA1 Amlenetug has previously received Orphan Drug Designation (ODD) from the US FDA and the EMA in Europe, in addition to SAKIGAK
HEFEI, China, Oct. 2, 2025 -- Reported by Hefei Daily: On September 28, the curtain rose at the Anhui Baixi Theatre for the opening of Operas Gathering in Anhui • Stars Shining in Hefei, a sweeping celebration of traditional Chinese opera that unites many of the nation's most acclaimed performers on one stage. The launch ceremony featured provincial leaders, including Liang Yanshun, Secretary of the CPC Anhui Provincial Committee, who formally opened the event. Among those in attendance were Governor Wang Qingxian, Provincial CPPCC Chairman Tang Liangzhi, and other officials. Fei Gaoyu
Bold new developments announced, and milestones reached Multi-million-euro partnership with ION Group for an R&D Innovation Campus East Village, a new Ellinikon neighborhood launched ATHENS, Greece, Oct. 2, 2025 -- The Ellinikon, Europe's biggest urban regeneration project, is moving forward at full speed. With construction now underway across more than 40 active sites involving approx. 3.000 workers and 18 leading contractors, LAMDA Development is delivering major milestones across its visionary master plan on the Athenian Riviera. The Ellinikon, Europe
大胆な新開発計画を発表、重要な節目を達成 ION Groupと数百万ユーロ規模の提携で研究開発イノベーションキャンパスを設立 Ellinikonの新たな地区「East Village」が誕生 アテネ(ギリシャ), 2025年10月2日 -- 欧州最大級の都市再生プロジェクト「The Ellinikon」が全速力で進展しています。現在、40以上の建設現場で作業が進行中で、約3,000人の作業員と18社の主要建設会社が携わる中、LAMDA Developmentはアテネ・リビエラにおける先見的なマスタープランの主要なマイルストーンを達成しています。 欧州を代表する都市再生プロジェクト「The Ellinikon」、全速力で前進 欧州におけるAIとデジタル化のハブ創出 8月28日、LAMDA Developmentは、グローバル金融テクノロジー企業であるION Groupから、The Ellinikon内の土地取得に関する拘束力のある提案を受諾しました。同地には、44カ国から約2,000名の専門家が集結するグローバル研究開発・イノベーションキャンパスが開発されます。 ION Groupが2つの異なる地区に開発するこのキャンパスは、最大建築面積約25万平方メートルを有します